PMC:7253482 / 1491-2299
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
67 | 690-695 | Gene | denotes | spike | Gene:43740568 |
68 | 0-13 | Species | denotes | Coronaviruses | Tax:11118 |
69 | 15-19 | Species | denotes | CoVs | Tax:11118 |
70 | 115-121 | Species | denotes | humans | Tax:9606 |
71 | 132-136 | Species | denotes | CoVs | Tax:11118 |
72 | 178-183 | Species | denotes | human | Tax:9606 |
73 | 223-268 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
74 | 270-278 | Species | denotes | SARS-CoV | Tax:694009 |
75 | 290-345 | Species | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) | Tax:1335626 |
76 | 377-387 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
77 | 521-527 | Species | denotes | humans | Tax:9606 |
78 | 70-91 | Disease | denotes | respiratory disorders | MESH:D012131 |
79 | 402-411 | Disease | denotes | mortality | MESH:D003643 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T10 | 700-708 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 70-91 | Disease | denotes | respiratory disorders | http://purl.obolibrary.org/obo/MONDO_0005087 |
T7 | 223-256 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 270-278 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 270-274 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 377-385 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 377-381 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 147-148 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 178-183 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T10 | 521-527 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T11 | 677-682 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 700-708 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 35-44 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
T7 | 82-91 | http://purl.obolibrary.org/obo/OGMS_0000045 | denotes | disorders |
T8 | 630-639 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T225 | 0-13 | NNS | denotes | Coronaviruses |
T226 | 14-15 | -LRB- | denotes | ( |
T227 | 15-19 | NNS | denotes | CoVs |
T228 | 19-20 | -RRB- | denotes | ) |
T229 | 21-24 | VBP | denotes | are |
T230 | 25-34 | VBN | denotes | enveloped |
T231 | 35-44 | NNS | denotes | pathogens |
T232 | 45-56 | JJ | denotes | responsible |
T233 | 57-60 | IN | denotes | for |
T234 | 61-69 | JJ | denotes | multiple |
T235 | 70-81 | JJ | denotes | respiratory |
T236 | 82-91 | NNS | denotes | disorders |
T237 | 92-94 | IN | denotes | of |
T238 | 95-102 | VBG | denotes | varying |
T239 | 103-111 | NN | denotes | severity |
T240 | 112-114 | IN | denotes | in |
T241 | 115-122 | NN | denotes | humans1 |
T242 | 124-131 | JJ | denotes | Certain |
T243 | 132-136 | NNS | denotes | CoVs |
T244 | 137-146 | VBP | denotes | represent |
T245 | 147-148 | DT | denotes | a |
T246 | 149-160 | JJ | denotes | significant |
T247 | 161-167 | NN | denotes | threat |
T248 | 168-170 | TO | denotes | to |
T249 | 171-177 | JJ | denotes | global |
T250 | 178-183 | JJ | denotes | human |
T251 | 184-190 | NN | denotes | health |
T252 | 190-191 | -COMMA- | denotes | , |
T253 | 192-194 | IN | denotes | as |
T254 | 195-206 | VBN | denotes | illustrated |
T255 | 207-209 | IN | denotes | by |
T256 | 210-219 | NNS | denotes | outbreaks |
T257 | 220-222 | IN | denotes | of |
T258 | 223-229 | JJ | denotes | severe |
T259 | 230-235 | JJ | denotes | acute |
T260 | 236-247 | JJ | denotes | respiratory |
T261 | 248-256 | NN | denotes | syndrome |
T262 | 257-268 | NN | denotes | coronavirus |
T263 | 269-270 | -LRB- | denotes | ( |
T264 | 270-278 | NN | denotes | SARS-CoV |
T265 | 278-279 | -RRB- | denotes | ) |
T266 | 280-282 | IN | denotes | in |
T267 | 283-288 | CD | denotes | 20032 |
T268 | 288-289 | -COMMA- | denotes | , |
T269 | 290-296 | NNP | denotes | Middle |
T270 | 297-301 | NNP | denotes | East |
T271 | 302-313 | JJ | denotes | respiratory |
T272 | 314-322 | NN | denotes | syndrome |
T273 | 323-334 | NN | denotes | coronavirus |
T274 | 335-336 | -LRB- | denotes | ( |
T275 | 336-344 | NN | denotes | MERS-CoV |
T276 | 344-345 | -RRB- | denotes | ) |
T277 | 346-348 | IN | denotes | in |
T278 | 349-354 | CD | denotes | 20123 |
T279 | 354-355 | -COMMA- | denotes | , |
T280 | 356-359 | CC | denotes | and |
T281 | 360-364 | RBS | denotes | most |
T282 | 365-373 | RB | denotes | recently |
T283 | 374-376 | IN | denotes | of |
T284 | 377-388 | NN | denotes | SARS-CoV-24 |
T285 | 390-395 | VBN | denotes | Given |
T286 | 396-401 | PRP-DOLLAR- | denotes | their |
T287 | 402-411 | NN | denotes | mortality |
T288 | 412-417 | NNS | denotes | rates |
T289 | 417-418 | -COMMA- | denotes | , |
T290 | 419-422 | DT | denotes | the |
T291 | 423-430 | JJ | denotes | current |
T292 | 431-435 | NN | denotes | lack |
T293 | 436-438 | IN | denotes | of |
T294 | 439-447 | VBN | denotes | targeted |
T295 | 448-458 | NNS | denotes | treatments |
T296 | 459-462 | CC | denotes | and |
T297 | 463-471 | JJ | denotes | licensed |
T298 | 472-480 | NNS | denotes | vaccines |
T299 | 480-481 | -COMMA- | denotes | , |
T300 | 482-485 | CC | denotes | and |
T301 | 486-491 | PRP-DOLLAR- | denotes | their |
T302 | 492-500 | NN | denotes | capacity |
T303 | 501-503 | TO | denotes | to |
T304 | 504-512 | VB | denotes | transmit |
T305 | 513-520 | IN | denotes | between |
T306 | 521-527 | NNS | denotes | humans |
T307 | 528-531 | CC | denotes | and |
T308 | 532-538 | IN | denotes | across |
T309 | 539-546 | NNS | denotes | species |
T310 | 547-558 | NN | denotes | barriers5,6 |
T311 | 558-559 | -COMMA- | denotes | , |
T312 | 560-565 | EX | denotes | there |
T313 | 566-568 | VBZ | denotes | is |
T314 | 569-571 | DT | denotes | an |
T315 | 572-578 | JJ | denotes | urgent |
T316 | 579-583 | NN | denotes | need |
T317 | 584-587 | IN | denotes | for |
T318 | 588-597 | JJ | denotes | effective |
T319 | 598-613 | NNS | denotes | countermeasures |
T320 | 614-616 | TO | denotes | to |
T321 | 617-623 | VB | denotes | combat |
T322 | 624-629 | DT | denotes | these |
T323 | 630-639 | NNS | denotes | pathogens |
T324 | 641-648 | VBG | denotes | Ongoing |
T325 | 649-656 | NN | denotes | vaccine |
T326 | 657-668 | NN | denotes | development |
T327 | 669-676 | NNS | denotes | efforts |
T328 | 677-682 | NN | denotes | focus |
T329 | 683-685 | IN | denotes | on |
T330 | 686-689 | DT | denotes | the |
T331 | 690-695 | NN | denotes | spike |
T332 | 696-697 | -LRB- | denotes | ( |
T333 | 697-698 | NN | denotes | S |
T334 | 698-699 | -RRB- | denotes | ) |
T335 | 700-708 | NNS | denotes | proteins |
T336 | 709-713 | WDT | denotes | that |
T337 | 714-722 | VBP | denotes | protrude |
T338 | 723-727 | IN | denotes | from |
T339 | 728-731 | DT | denotes | the |
T340 | 732-737 | JJ | denotes | viral |
T341 | 738-746 | NN | denotes | envelope |
T342 | 747-750 | CC | denotes | and |
T343 | 751-761 | VB | denotes | constitute |
T344 | 762-765 | DT | denotes | the |
T345 | 766-770 | JJ | denotes | main |
T346 | 771-777 | NN | denotes | target |
T347 | 778-780 | IN | denotes | of |
T348 | 781-793 | VBG | denotes | neutralizing |
T349 | 794-807 | NN | denotes | antibodies7,8 |
R221 | T225 | T226 | arg1Of | Coronaviruses,( |
R222 | T227 | T226 | arg2Of | CoVs,( |
R223 | T228 | T226 | arg3Of | ),( |
R224 | T225 | T229 | arg1Of | Coronaviruses,are |
R225 | T231 | T229 | arg2Of | pathogens,are |
R226 | T231 | T230 | arg2Of | pathogens,enveloped |
R227 | T231 | T232 | arg1Of | pathogens,responsible |
R228 | T232 | T233 | arg1Of | responsible,for |
R229 | T236 | T233 | arg2Of | disorders,for |
R230 | T236 | T234 | arg1Of | disorders,multiple |
R231 | T236 | T235 | arg1Of | disorders,respiratory |
R232 | T236 | T237 | arg1Of | disorders,of |
R233 | T239 | T237 | arg2Of | severity,of |
R234 | T239 | T238 | arg1Of | severity,varying |
R235 | T239 | T240 | arg1Of | severity,in |
R236 | T241 | T240 | arg2Of | humans1,in |
R237 | T243 | T242 | arg1Of | CoVs,Certain |
R238 | T243 | T244 | arg1Of | CoVs,represent |
R239 | T247 | T244 | arg2Of | threat,represent |
R240 | T247 | T245 | arg1Of | threat,a |
R241 | T247 | T246 | arg1Of | threat,significant |
R242 | T247 | T248 | arg1Of | threat,to |
R243 | T251 | T248 | arg2Of | health,to |
R244 | T251 | T249 | arg1Of | health,global |
R245 | T251 | T250 | arg1Of | health,human |
R246 | T244 | T252 | arg1Of | represent,"," |
R247 | T244 | T253 | arg1Of | represent,as |
R248 | T254 | T253 | arg2Of | illustrated,as |
R249 | T256 | T254 | arg1Of | outbreaks,illustrated |
R250 | T256 | T255 | arg2Of | outbreaks,by |
R251 | T256 | T257 | arg1Of | outbreaks,of |
R252 | T262 | T257 | arg2Of | coronavirus,of |
R253 | T262 | T258 | arg1Of | coronavirus,severe |
R254 | T262 | T259 | arg1Of | coronavirus,acute |
R255 | T262 | T260 | arg1Of | coronavirus,respiratory |
R256 | T262 | T261 | arg1Of | coronavirus,syndrome |
R257 | T262 | T263 | arg1Of | coronavirus,( |
R258 | T264 | T263 | arg2Of | SARS-CoV,( |
R259 | T265 | T263 | arg3Of | ),( |
R260 | T262 | T266 | arg1Of | coronavirus,in |
R261 | T267 | T266 | arg2Of | 20032,in |
R262 | T256 | T268 | arg1Of | outbreaks,"," |
R263 | T273 | T268 | arg2Of | coronavirus,"," |
R264 | T270 | T269 | arg1Of | East,Middle |
R265 | T273 | T270 | arg1Of | coronavirus,East |
R266 | T273 | T271 | arg1Of | coronavirus,respiratory |
R267 | T273 | T272 | arg1Of | coronavirus,syndrome |
R268 | T273 | T274 | arg1Of | coronavirus,( |
R269 | T275 | T274 | arg2Of | MERS-CoV,( |
R270 | T276 | T274 | arg3Of | ),( |
R271 | T273 | T277 | arg1Of | coronavirus,in |
R272 | T278 | T277 | arg2Of | 20123,in |
R273 | T280 | T279 | arg1Of | and,"," |
R274 | T277 | T280 | arg1Of | in,and |
R275 | T283 | T280 | arg2Of | of,and |
R276 | T282 | T281 | arg1Of | recently,most |
R277 | T283 | T282 | arg1Of | of,recently |
R278 | T273 | T283 | arg1Of | coronavirus,of |
R279 | T284 | T283 | arg2Of | SARS-CoV-24,of |
R280 | T313 | T285 | arg1Of | is,Given |
R281 | T300 | T285 | arg2Of | and,Given |
R282 | T288 | T286 | arg1Of | rates,their |
R283 | T288 | T287 | arg1Of | rates,mortality |
R284 | T288 | T289 | arg1Of | rates,"," |
R285 | T292 | T289 | arg2Of | lack,"," |
R286 | T292 | T290 | arg1Of | lack,the |
R287 | T292 | T291 | arg1Of | lack,current |
R288 | T292 | T293 | arg1Of | lack,of |
R289 | T296 | T293 | arg2Of | and,of |
R290 | T295 | T294 | arg2Of | treatments,targeted |
R291 | T295 | T296 | arg1Of | treatments,and |
R292 | T298 | T296 | arg2Of | vaccines,and |
R293 | T298 | T297 | arg1Of | vaccines,licensed |
R294 | T300 | T299 | arg1Of | and,"," |
R295 | T289 | T300 | arg1Of | ",",and |
R296 | T302 | T300 | arg2Of | capacity,and |
R297 | T302 | T301 | arg1Of | capacity,their |
R298 | T304 | T303 | arg1Of | transmit,to |
R299 | T302 | T303 | modOf | capacity,to |
R300 | T304 | T305 | arg1Of | transmit,between |
R301 | T306 | T305 | arg2Of | humans,between |
R302 | T285 | T307 | arg1Of | Given,and |
R303 | T308 | T307 | arg2Of | across,and |
R304 | T313 | T308 | arg1Of | is,across |
R305 | T310 | T308 | arg2Of | "barriers5,6",across |
R306 | T310 | T309 | arg1Of | "barriers5,6",species |
R307 | T313 | T311 | arg1Of | is,"," |
R308 | T312 | T313 | arg1Of | there,is |
R309 | T316 | T313 | arg2Of | need,is |
R310 | T316 | T314 | arg1Of | need,an |
R311 | T316 | T315 | arg1Of | need,urgent |
R312 | T316 | T317 | arg1Of | need,for |
R313 | T319 | T317 | arg2Of | countermeasures,for |
R314 | T321 | T317 | arg3Of | combat,for |
R315 | T319 | T318 | arg1Of | countermeasures,effective |
R316 | T321 | T320 | arg1Of | combat,to |
R317 | T319 | T321 | arg1Of | countermeasures,combat |
R318 | T323 | T321 | arg2Of | pathogens,combat |
R319 | T323 | T322 | arg1Of | pathogens,these |
R320 | T328 | T324 | arg1Of | focus,Ongoing |
R321 | T328 | T325 | arg1Of | focus,vaccine |
R322 | T328 | T326 | arg1Of | focus,development |
R323 | T328 | T327 | arg1Of | focus,efforts |
R324 | T328 | T329 | arg1Of | focus,on |
R325 | T335 | T329 | arg2Of | proteins,on |
R326 | T335 | T330 | arg1Of | proteins,the |
R327 | T335 | T331 | arg1Of | proteins,spike |
R328 | T335 | T332 | arg1Of | proteins,( |
R329 | T333 | T332 | arg2Of | S,( |
R330 | T334 | T332 | arg3Of | ),( |
R331 | T335 | T336 | arg1Of | proteins,that |
R332 | T335 | T337 | arg1Of | proteins,protrude |
R333 | T337 | T338 | arg1Of | protrude,from |
R334 | T341 | T338 | arg2Of | envelope,from |
R335 | T341 | T339 | arg1Of | envelope,the |
R336 | T341 | T340 | arg1Of | envelope,viral |
R337 | T337 | T342 | arg1Of | protrude,and |
R338 | T343 | T342 | arg2Of | constitute,and |
R339 | T335 | T343 | arg1Of | proteins,constitute |
R340 | T346 | T343 | arg2Of | target,constitute |
R341 | T346 | T344 | arg1Of | target,the |
R342 | T346 | T345 | arg1Of | target,main |
R343 | T346 | T347 | arg1Of | target,of |
R344 | T348 | T347 | arg2Of | neutralizing,of |
R345 | T349 | T348 | arg2Of | "antibodies7,8",neutralizing |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T10 | 700-708 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 700-708 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T11 | 178-183 | Species | denotes | human | NCBItxid:9606 |
T12 | 223-256 | Species | denotes | severe acute respiratory syndrome | NCBItxid:694009 |
T13 | 270-278 | Species | denotes | SARS-CoV | NCBItxid:694009 |
T14 | 270-274 | Species | denotes | SARS | NCBItxid:694009 |
T15 | 290-334 | Species | denotes | Middle East respiratory syndrome coronavirus | NCBItxid:1335626 |
T16 | 336-344 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
T17 | 377-385 | Species | denotes | SARS-CoV | NCBItxid:694009 |
T18 | 377-381 | Species | denotes | SARS | NCBItxid:694009 |
T19 | 521-527 | Species | denotes | humans | NCBItxid:9605 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 0-123 | Sentence | denotes | Coronaviruses (CoVs) are enveloped pathogens responsible for multiple respiratory disorders of varying severity in humans1. |
T13 | 124-389 | Sentence | denotes | Certain CoVs represent a significant threat to global human health, as illustrated by outbreaks of severe acute respiratory syndrome coronavirus (SARS-CoV) in 20032, Middle East respiratory syndrome coronavirus (MERS-CoV) in 20123, and most recently of SARS-CoV-24. |
T14 | 390-640 | Sentence | denotes | Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens. |
T15 | 641-808 | Sentence | denotes | Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8. |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 70-91 | Disease | denotes | respiratory disorders | http://purl.obolibrary.org/obo/MONDO_0005087 |
T7 | 223-256 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 270-278 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 270-274 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 377-385 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 377-381 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
78 | 70-91 | Disease | denotes | respiratory disorders | MESH:D012131 |
70 | 115-121 | Species | denotes | humans | Tax:9606 |
71 | 132-136 | Species | denotes | CoVs | Tax:11118 |
72 | 178-183 | Species | denotes | human | Tax:9606 |
73 | 223-268 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
74 | 270-278 | Species | denotes | SARS-CoV | Tax:694009 |
75 | 290-345 | Species | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) | Tax:1335626 |
76 | 377-387 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
79 | 402-411 | Disease | denotes | mortality | MESH:D003643 |
77 | 521-527 | Species | denotes | humans | Tax:9606 |
67 | 690-695 | Gene | denotes | spike | Gene:43740568 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T714 | 696-708 | Protein | denotes | (S) proteins | https://www.uniprot.org/uniprot/Q9UIP0|https://www.uniprot.org/uniprot/Q9UIN9|https://www.uniprot.org/uniprot/Q9UIN8|https://www.uniprot.org/uniprot/Q9UIN7|https://www.uniprot.org/uniprot/Q9UIN6|https://www.uniprot.org/uniprot/Q9UBH8|https://www.uniprot.org/uniprot/Q9NRH8|https://www.uniprot.org/uniprot/Q9NRH7|https://www.uniprot.org/uniprot/Q9NRH6|https://www.uniprot.org/uniprot/Q9NRH5|https://www.uniprot.org/uniprot/Q9NRH4|https://www.uniprot.org/uniprot/Q9NPG5|https://www.uniprot.org/uniprot/Q9NPE0|https://www.uniprot.org/uniprot/Q9NP52|https://www.uniprot.org/uniprot/Q95IF9|https://www.uniprot.org/uniprot/Q8N5P3|https://www.uniprot.org/uniprot/Q8IZU6|https://www.uniprot.org/uniprot/Q8IZU5|https://www.uniprot.org/uniprot/Q8IZU4|https://www.uniprot.org/uniprot/Q86Z04|https://www.uniprot.org/uniprot/Q7YR44|https://www.uniprot.org/uniprot/Q7LA71|https://www.uniprot.org/uniprot/Q7LA70|https://www.uniprot.org/uniprot/Q5STD2|https://www.uniprot.org/uniprot/Q5SQ85|https://www.uniprot.org/uniprot/Q1XI16|https://www.uniprot.org/uniprot/Q1XI12|https://www.uniprot.org/uniprot/Q15517|https://www.uniprot.org/uniprot/O43509|https://www.uniprot.org/uniprot/O19084|https://www.uniprot.org/uniprot/B0UYZ7|https://www.uniprot.org/uniprot/B0S7V2|https://www.uniprot.org/uniprot/A5A6L9 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 0-123 | Sentence | denotes | Coronaviruses (CoVs) are enveloped pathogens responsible for multiple respiratory disorders of varying severity in humans1. |
T13 | 124-389 | Sentence | denotes | Certain CoVs represent a significant threat to global human health, as illustrated by outbreaks of severe acute respiratory syndrome coronavirus (SARS-CoV) in 20032, Middle East respiratory syndrome coronavirus (MERS-CoV) in 20123, and most recently of SARS-CoV-24. |
T14 | 390-640 | Sentence | denotes | Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens. |
T15 | 641-808 | Sentence | denotes | Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8. |